Patrick A. Oberholzer

MEK1 mutations confer resistance to MEK and B-RAF inhibition

Krishna G. Vijayendran, Marie Zipser, Allison M. Sawyer et al. · Proceedings of the National Academy of Sciences · 2009 · 634 citations · Full text

Medicine, Cancer Biology, Oncology +17

<i>RAS</i> Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors

Patrick A. Oberholzer, Damien Kee, Piotr Dziunycz et al. · Journal of Clinical Oncology · 2011 · 381 citations · Full text

Medicine, Oncology, Pharmacology +16

Induction of Genes Mediating Interferon-dependent Extracellular Trap Formation during Neutrophil Differentiation

Sibylla Martinelli, Mirjana Urosevic, Arezoo Daryadel et al. · Journal of Biological Chemistry · 2004 · 287 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells

Lucie Heinzerling, Valérie Künzi, Patrick A. Oberholzer et al. · Blood · 2005 · 187 citations · Full text

Medicine, Immunology, Oncology +17

Selective Nerve Root Blocks for the Treatment of Sciatica: Evaluation of Injection Site and Effectiveness—A Study with Patients and Cadavers

Christian W. A. Pfirrmann, Patrick A. Oberholzer, Marco Zanetti et al. · Radiology · 2001 · 184 citations

Medicine, Neurological Surgery, Radiology +12